The ?Spinal Muscular Atrophy: Pipeline Review, Developer Landscape and Competitive Insights, 2021-2031? report features an extensive study on the marketed, clinical and preclinical molecules available / being developed for the treatment of spinal muscular atrophy. This report provides an in-depth analysis of the product pipeline and developer companies, highlighting the current treatment practices
02 Creations Llc
Gain Edge Consulting
Hartmann Wiley
Huffman Waddell
Bentzen Avery
Guy Mackinnon
Otto Bro
Mcleod Robles
Ejlersen Bjerre
Risager Rosen